Evaluating the effectiveness of elimination diet in infants with CMP-induced allergic proctocolitis using CoMiSS.

IF 3.1 3区 医学 Q1 PEDIATRICS
Menşure Nur Çelik, Eda Köksal, Sinem Polat Terece, Gizem Köken, Hacer İlbilge Ertoy Karagöl, Arzu Bakirtas
{"title":"Evaluating the effectiveness of elimination diet in infants with CMP-induced allergic proctocolitis using CoMiSS.","authors":"Menşure Nur Çelik, Eda Köksal, Sinem Polat Terece, Gizem Köken, Hacer İlbilge Ertoy Karagöl, Arzu Bakirtas","doi":"10.1038/s41390-025-04117-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There are no data on using the Cow's Milk Protein Related Symptom Score (CoMiSS), a clinical screening tool, to monitor symptom improvement in infants with cow's milk protein allergy (CMPA). This study aimed to evaluate the efficacy of CoMiSS on elimination diet response in infants diagnosed with Cow's Milk Protein Associated Proctocolitis (CMPAP) compared with healthy controls METHODS: A case-control study with follow-up compared infants with CMPAP on an elimination diet to healthy peers. Infants with CMPAP (n = 13) and healthy infants (n = 22), aged 17-26 weeks, were included. Four visits were conducted at six, seven, nine, and 12 months of age. CoMiSS was assessed at each visit.</p><p><strong>Results: </strong>CoMiSS significantly decreased after the four-week elimination diet (p < 0.05). At study's end, total CoMiSS scores increased in both groups (p < 0.05). The crying score's median was higher in CMPAP infants than controls at Visits 1 and 3 (p < 0.05). No significant changes were found for other symptoms.</p><p><strong>Conclusions: </strong>CoMiSS tends to decrease during elimination diet in infants with CMPAP, which is promising for its use in evaluating dietary response. Monitoring the crying score and developing the defecation score specific to CMPAP would serve this purpose more.</p><p><strong>Impact: </strong>The CoMiSS can be a promising tool for monitoring responses to elimination diets in infants with proctocolitis, a specific subgroup of CMPA. It highlights the potential of CoMiSS to monitor dietary response and suggests refinements for its application, such as focusing on crying scores and developing a CMPA-specific defecation score. The findings pave the way for a novel use of CoMiSS beyond its screening purpose, potentially enhancing clinical management of CMPA in infants with proctocolitis. This approach could lead to more tailored and effective dietary interventions, improving patient outcomes and contributing to the refinement of CMPA management tools.</p>","PeriodicalId":19829,"journal":{"name":"Pediatric Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41390-025-04117-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There are no data on using the Cow's Milk Protein Related Symptom Score (CoMiSS), a clinical screening tool, to monitor symptom improvement in infants with cow's milk protein allergy (CMPA). This study aimed to evaluate the efficacy of CoMiSS on elimination diet response in infants diagnosed with Cow's Milk Protein Associated Proctocolitis (CMPAP) compared with healthy controls METHODS: A case-control study with follow-up compared infants with CMPAP on an elimination diet to healthy peers. Infants with CMPAP (n = 13) and healthy infants (n = 22), aged 17-26 weeks, were included. Four visits were conducted at six, seven, nine, and 12 months of age. CoMiSS was assessed at each visit.

Results: CoMiSS significantly decreased after the four-week elimination diet (p < 0.05). At study's end, total CoMiSS scores increased in both groups (p < 0.05). The crying score's median was higher in CMPAP infants than controls at Visits 1 and 3 (p < 0.05). No significant changes were found for other symptoms.

Conclusions: CoMiSS tends to decrease during elimination diet in infants with CMPAP, which is promising for its use in evaluating dietary response. Monitoring the crying score and developing the defecation score specific to CMPAP would serve this purpose more.

Impact: The CoMiSS can be a promising tool for monitoring responses to elimination diets in infants with proctocolitis, a specific subgroup of CMPA. It highlights the potential of CoMiSS to monitor dietary response and suggests refinements for its application, such as focusing on crying scores and developing a CMPA-specific defecation score. The findings pave the way for a novel use of CoMiSS beyond its screening purpose, potentially enhancing clinical management of CMPA in infants with proctocolitis. This approach could lead to more tailored and effective dietary interventions, improving patient outcomes and contributing to the refinement of CMPA management tools.

使用CoMiSS评估消除饮食对cmp诱发的过敏性直结肠炎婴儿的有效性。
背景:目前尚无使用牛奶蛋白相关症状评分(CoMiSS)这一临床筛查工具来监测牛奶蛋白过敏(CMPA)婴儿症状改善的数据。本研究旨在评估CoMiSS对诊断为牛奶蛋白相关性直结肠炎(CMPAP)的婴儿消除饮食反应的效果,并与健康对照组进行比较。方法:一项随访的病例对照研究,将CMPAP婴儿与健康同行进行消除饮食比较。纳入17-26周龄的CMPAP患儿(n = 13)和健康患儿(n = 22)。在6个月、7个月、9个月和12个月时进行了四次访问。在每次访问时评估CoMiSS。结论:CoMiSS在CMPAP婴儿的消除饮食中有降低的趋势,这有望用于评估饮食反应。监测哭闹评分和制定CMPAP专用的排便评分将更有助于实现这一目的。影响:CoMiSS可以作为一种很有前景的工具,用于监测患有CMPA的特定亚组——直结肠炎的婴儿对消除饮食的反应。它强调了CoMiSS在监测饮食反应方面的潜力,并建议对其应用进行改进,例如专注于哭泣评分和开发cmpa特异性排便评分。这一发现为CoMiSS在筛查目的之外的新应用铺平了道路,潜在地增强了婴儿直结肠炎CMPA的临床管理。这种方法可能导致更有针对性和更有效的饮食干预,改善患者的预后,并有助于改进CMPA管理工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Research
Pediatric Research 医学-小儿科
CiteScore
6.80
自引率
5.60%
发文量
473
审稿时长
3-8 weeks
期刊介绍: Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of children''s diseases and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信